Inventor · disambiguated record
Yves Chantigny
Also filed as: CHANTIGNY YVES · CHANTIGNY YVES A · CHANTIGNY YVES ANDRE
11 granted patents·8 pending applications·24 citations·filing 2003–2023
84Inventor score
Top patents by PatentIndex Score
19 records- 0183US7138406B2Modulators of the glucocorticoid receptorPFIZER PROD INC·Filed 2003·Granted Nov 21, 2006·18 cites·64 claims
- 0278US7553877B2Modulators of the glucocorticoid receptorPFIZER·Filed 2006·Granted Jun 30, 2009·3 cites·4 claims
- 0374US12286426B2Heterocyclic mitochondrial activity inhibitors and uses thereofUNIV MONTREAL·Filed 2023·Granted Apr 29, 2025·0 cites·19 claims
- 0473US9636298B2Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugsMETHYLGENE INC·Filed 2015·Granted May 2, 2017·1 cites·7 claims
- 0572US2023338429A1Compounds and use thereof in the expansion of stem cells and/or progenitor cellsUNIV MONTREAL·Filed 2023·Application pending·0 cites
- 0666US8399452B2Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitorsDEZIEL ROBERT·Filed 2007·Granted Mar 19, 2013·1 cites·52 claims
- 0765US11760754B2Heterocyclic mitochondrial activity inhibitors and uses thereofUNIV MONTREAL·Filed 2018·Granted Sep 19, 2023·0 cites·6 claims
- 0865US9493456B2Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulatorsUNIV MONTREAL·Filed 2015·Granted Nov 15, 2016·1 cites·14 claims
- 0963US11696928B2Compounds and use thereof in the expansion of stem cells and/or progenitor cellsUNIV MONTREAL·Filed 2018·Granted Jul 11, 2023·0 cites·11 claims
- 1059US9193749B2Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitorsFORUM PHARMACEUTICALS INC·Filed 2013·Granted Nov 24, 2015·0 cites·2 claims
- 1152US2013165426A1Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulatorsRUEL REJEAN·Filed 2011·Application pending·0 cites
- 1252US2016296507A1Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulatorsUNIV MONTREAL·Filed 2016·Application pending·0 cites
- 1350US2016222026A1Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC InhibitorsFORUM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1446US2007293530A1Sulfamide and sulfamate derivatives as histone deacetylase inhibitorsMETHYLGENE INC·Filed 2007·Application pending·0 cites
- 1546US2011196147A1Inhibitors of histone deacetylaseDEZIEL ROBERT·Filed 2011·Application pending·0 cites
- 1643US9018395B2Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulatorsBOUVIER MICHEL·Filed 2012·Granted Apr 28, 2015·0 cites·12 claims
- 1742US2007155730A1Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone DeacetylaseMETHYLGENE INC·Filed 2006·Application pending·0 cites
- 1840US9096565B2Inhibitors of histone deacetylaseTESSIER PIERRE·Filed 2008·Granted Aug 4, 2015·0 cites·5 claims
- 1938US2006264415A1Inhibitors of histone deacetylaseMETHYLGENE INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yves Chantigny files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →